DARREN HOPES / IKON IMAGES / SCIENCE PHOTO LIBRARY
Migraine remains a debilitating and stigmatised health condition. Often dismissed as ‘just a bad headache’, patients struggle to access the care and treatment they need.
As part of a new campaign, we want to understand your experience in supporting patients with migraine across pharmacy, including in identification and diagnosis of the condition. Given the changing treatment landscape, we also want to understand your awareness and knowledge of treatment availability and the additional support, including referral options, that are accessible to patients in your local area.
Please tell us about your experience by completing this short survey.
We would be grateful if community pharmacists, as clinical leads in pharmacies, could please forward the survey link on to their community pharmacy team to complete, including pharmacy technicians and medicines counter assistants. In addition, we would like to hear from pharmacy students and foundation trainees.
The outputs of the survey will be used to develop resources that meet the learning needs of pharmacists and their teams and define best practice across pharmacy.
All eligible respondents who fully complete the survey by 11 June 2025 (deadline extended) will be entered into a prize draw to win one of three £100 ‘One4all’ vouchers.
No personal details will be published or made available to third parties.
Thank you for your participation.
The Pharmaceutical Journal team
Financial support was provided from Pfizer Ltd. Pfizer have provided only financial support and have had no input into the development or content of the project and associated materials.
Please note: Personal data will remain securely held on our systems. We will only contact you regarding the prize draw for this survey, or if you indicate you are happy to be contacted about content arising from this survey or to participate in focus groups.
For further details please visit: The Pharmaceutical Journal terms and conditions and The Pharmaceutical Journal cookie and privacy policies.
